Loading...
XNASXOMA
Market cap303mUSD
Jan 08, Last price  
25.74USD
1D
0.27%
1Q
-3.99%
Jan 2017
509.95%
Name

XOMA Corp

Chart & Performance

D1W1MN
XNAS:XOMA chart
P/E
—
P/S
63.74
EPS
—
Div Yield, %
1.80%
Shrs. gr., 5y
6.50%
Rev. gr., 5y
-2.13%
Revenues
5m
-21.06%
3,665,00018,669,00029,498,00084,252,00067,987,00098,430,00033,641,00058,196,00033,782,00035,451,00018,866,00055,447,0005,564,00052,690,0005,299,00018,370,00029,385,00038,160,0006,027,0004,758,000
Net income
-41m
L+138.72%
-78,942,0002,779,000-51,841,000-12,326,000-45,245,000550,000-68,756,000-32,743,000-71,065,000-124,058,000-38,301,000-20,606,000-53,530,00014,596,000-13,343,000-7,698,00013,298,00015,798,000-17,104,000-40,831,000
CFO
-18m
L+40.99%
-44,827,000-44,190,000-33,270,0004,543,000-32,975,0007,435,000-52,537,000-29,062,000-40,765,000-45,915,000-78,282,000-30,892,000-33,689,0002,686,000-12,644,000-285,00010,092,00022,678,000-12,879,000-18,158,000
Dividend
Apr 02, 20240 USD/sh
Earnings
Mar 06, 2025

Profile

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
URL
https://www.xoma.com/
IPO date
Jun 06, 1986
Employees
11
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,758
-21.06%
6,027
-84.21%
Cost of revenue
26,646
23,441
Unusual Expense (Income)
NOPBT
(21,888)
(17,414)
NOPBT Margin
Operating Taxes
(15)
Tax Rate
NOPAT
(21,888)
(17,399)
Net income
(40,831)
138.72%
(17,104)
-208.27%
Dividends
(5,472)
(5,472)
Dividend yield
1.88%
2.61%
Proceeds from repurchase of equity
(148)
1,021
BB yield
0.05%
-0.49%
Debt
Debt current
5,651
34
Long-term debt
119,242
68
Deferred revenue
7,228
9,550
Other long-term liabilities
(34)
Net debt
(28,558)
(121,742)
Cash flow
Cash from operating activities
(18,158)
(12,879)
CAPEX
(17)
(23,247)
Cash from investing activities
(711)
(20,221)
Cash from financing activities
120,593
(4,451)
FCF
(24,109)
(17,222)
Balance
Cash
153,451
58,161
Long term investments
63,683
Excess cash
153,213
121,543
Stockholders' equity
(1,223,088)
(1,182,257)
Invested Capital
1,443,541
1,315,855
ROIC
ROCE
EV
Common stock shares outstanding
11,471
11,413
Price
25.41
38.10%
18.40
-11.75%
Market cap
291,479
38.80%
209,999
-17.39%
EV
262,970
88,306
EBITDA
(20,988)
(17,310)
EV/EBITDA
Interest
569
295
Interest/NOPBT